ImmunovantIMVT 
$26.28-4.75%24h
-4.75%24h
Global rank3390
Market cap$3.80B
Change 7d-7.79%
YTD Performance-36.67%
SP500 benchmarkUnderperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Category
Market capitalization of Immunovant (IMVT)
As of December 2024, Immunovant has a market cap of $3.80B. This makes Immunovant the world's 3390th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Market cap history of Immunovant from 2019 to 2024
-
Value:-
Market cap history of Immunovant from 2019 to 2024
| Year | Market Cap | Change |
|---|---|---|
| 2024 | $5.49B | -9.92% |
| 2023 | $6.09B | 137.35% |
| 2022 | $2.57B | 108.33% |
| 2021 | $1.23B | -81.55% |
| 2020 | $6.68B | 191.05% |
| 2019 | $2.30B | - |
IMVT Market Cap Today is $3.80B -4.75% - 15 Dec 2024
View largest stocks by market cap 
